Medical Journals

Ablation of Proliferating Marrow with 5-fluorouracil Allows Partial Purification of Mesenchymal Stem Cells.

Authors:
  • Wang Zhuo
  • Song Junhui
  • Taichman Russell S
  • Krebsbach Paul H

From: Department of Biologic and Materials Sciences, University of Michigan School of Dentistry, Ann Arbor, 48109, USA.

Stem cells (Dayton, Ohio)

  • Publish Date: Jun 2006
  • ISSN: 1066-5099
  • Volume: 24
  • Issue: 6
  • Pages: 1573-82
  • Medium: Print
  • Language: English
  • Citation (JAMA): Wang Zhuo, Song Junhui, Taichman Russell S, et al. Ablation of Proliferating Marrow with 5-fluorouracil Allows Partial Purification of Mesenchymal Stem Cells.. Stem Cells Jun 2006;24:1573-82

Abstract

The ability to identify and maintain mesenchymal stem cells in vitro is a prerequisite for the ex vivo expansion of cells capable of effecting mesenchymal tissue regeneration. The aim of this investigation was to develop an assay to enrich and ultimately purify mesenchymal stem cells. To enrich the population of mesenchymal stem cell-like cells, rats or mice were administered 5-fluorouracil (5-FU) in vivo. Limiting dilution analysis demonstrated that 5-FU-treated bone marrow had the potential to form colony-forming units-fibroblastic (CFU-F) at a 10-fold or sixfold enrichment compared to normal bone marrow in rats or mice, respectively. In vivo and in vitro differentiation assays supported the enrichment and purification effects. In vitro, bone marrow cultures from 5-FU-treated bone marrow demonstrated lineage-specific gene expression in lineage-specific medium conditions in contrast to the multilineage gene expression of control bone marrow cultures. In vivo implantation of 5-FU-treated cells that were not expanded in culture generated ossicles containing an intact bone cortex and mature hematopoietic components, whereas non-5-FU-treated bone marrow only formed fibrous tissues. Our results demonstrate that enrichment of a quiescent cell population in the bone marrow by in vivo treatment of 5-FU spares those undifferentiated mesenchymal stem cells and influences the differentiation of bone marrow stromal cells in vitro and in vivo. This prospective identification of a population of mesenchymal cells from the marrow that maintain their multilineage potential should lead to more focused studies on the characterization of a true mesenchymal stem cell.

Mesh Headings (Keywords): Animals, Cell Differentiation, Cell Proliferation, Cell Separation, Cells, Cultured, Colony-Forming Units Assay, DNA, Complementary, Fluorouracil, Genetic Markers, Mesenchymal Stem Cell Transplantation, Mesenchymal Stem Cells, Mice, Mice, Inbred BALB C, Rats, Rats, Inbred F344, Transplantation, Isogeneic


Check for Full Text / PubMed Unique Identifier (PMID): 16769762


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.